Last updated: July 14, 2026
The clinical case for earlier arrhythmia detection is well established. In the TRUST trial, remote monitoring reduced the time to evaluation for arrhythmic events while also cutting total in-hospital device evaluations by 45% without affecting morbidity. The CONNECT trial reinforced these findings and showed that faster evaluation translates into clinical benefit, with wireless remote monitoring and automatic clinician alerts reducing the time from event occurrence to clinical decision and shortening mean hospitalization length.
Device-detected subclinical atrial tachyarrhythmias in patients over 65 with hypertension were associated with a 2.5-fold increased risk of ischemic stroke or systemic embolism. That association highlights why detection speed matters clinically, not just operationally. Beyond arrhythmia detection, remote monitoring also identifies hardware issues earlier than conventional follow-up, detecting generator and lead problems that require surgical revision before they escalate into device failure or patient harm.
Rhythm360 extends these gains across all OEMs through redundant data feeds, computer vision ingestion of unstructured PDFs, and AI-powered data normalization, achieving greater than 99.9% transmissibility. When an OEM server experiences downtime, Rhythm360’s fail-safe architecture continues capturing data. That continuity preserves the detection advantages documented in TRUST and CONNECT instead of allowing technical gaps in a single manufacturer’s infrastructure to delay care.
The hospitalization evidence for remote monitoring is substantial. A 2023 analysis of ICD and CRT-D patients at Trento’s Santa Chiara Hospital found that remote monitoring patients had lower rates of cardiovascular hospitalization over two years compared to the standard in-office monitoring group. That reduction translated into cost savings for payers and hospitals over the same period.
The TELESAT PRIOR-HF study found that patient-centered remote monitoring was associated with a reduction in HF-related hospitalizations, emergency department admissions, and cumulative days in the hospital compared to standard care. Meta-analyses have shown that remote monitoring is associated with a lower risk of HF-related hospitalization, reinforcing that these findings hold across different populations and study designs.
Rhythm360’s bi-directional EHR integration enables same-day intervention when a critical alert fires. Rather than a notification sitting in an unmonitored OEM portal queue, the alert appears in a prioritized dashboard, triggers a clinician notification, and links directly to the patient record. This workflow compresses the time from detection to clinical decision and supports the hospitalization reductions documented in the literature.
Alert volume is one of the primary reasons remote monitoring programs underperform. When every transmission generates an undifferentiated notification, clinicians develop alert fatigue and begin to deprioritize the queue. That environment is exactly where a critical event can be missed. Effective remote monitoring requires a triage layer that filters non-actionable transmissions and surfaces only the events that require immediate clinical attention.
Rhythm360’s AI-powered alert triage system applies this prioritization across all connected OEM data streams simultaneously. Routine transmissions are processed and documented automatically. Clinically significant events, such as new-onset atrial fibrillation, ventricular tachycardia, lead impedance anomalies, or battery depletion approaching elective replacement indicator, are escalated with context. The measurable result is an 80% reduction in critical alert response times compared to manual, portal-by-portal workflows. Practices can also supplement platform triage with 24/7/365 oversight from certified cardiac technicians (CCTs) supervised by physicians, adding a human layer to the AI-driven prioritization.
Remote monitoring consistently reduces visit frequency across published studies. The TRUST trial demonstrated the visit reduction effect at scale, with the 45% decrease in evaluations achieved without compromising patient outcomes. The MORE-CARE multicenter randomized controlled trial found that remote monitoring reduced scheduled follow-ups and accelerated clinical decision-making. University Hospitals of Leicester’s cardiac remote monitoring pilot achieved reductions in hospitalization rates and length of stay for those who were hospitalized, generating efficiency savings.
High-volume academic centers show how this model performs in real practice. University of Chicago Medicine reviewed more than 73,000 reports annually through Rhythm360 in calendar year 2025, averaging more than 18,000 reports per quarter, with stable dismissal rates. Andrew Beaser, MD, Associate Professor of Medicine at UCM, noted: “We are able to address these issues earlier; rather than waiting for a 3-month visit, we can call patients in for evaluation.” That shift from scheduled to clinically indicated visits reduces unnecessary patient travel, frees clinic capacity, and concentrates in-person resources on patients who genuinely need them.
The administrative cost of multi-OEM portal management is concrete and cumulative. Each additional manufacturer in a practice’s device population adds another login, another alert format, another documentation workflow, and another point of failure. Staff who spend hours per day navigating disparate systems have less time for direct patient care, and the risk of a missed transmission increases with every manual handoff.
Rhythm360 consolidates data from Medtronic, Boston Scientific, Abbott, Biotronik, and other manufacturers into a single dashboard. API, HL7, XML, and PDF data streams are ingested and normalized automatically. Clinicians access a unified patient record from any device, including a HIPAA-compliant mobile application, without toggling between portals. Gaurav A. Upadhyay, MD, at UCM, observed in a published case study: “We have improved billing and accountability for our patients after the integration.” The elimination of redundant logins and manual reconciliation also reduces dependence on a single “super-user,” protecting practices from operational disruption when key staff are unavailable.
Remote monitoring generates billable activity under CPT codes including 93298 and 99454, but capturing that revenue requires complete, auditable documentation for every qualifying transmission. Manual workflows routinely miss billable events because documentation is incomplete, transmissions are not reviewed within the required window, or the billing team lacks visibility into which patients have met the threshold for a given code. These gaps compound over time and leave significant revenue unclaimed.
Rhythm360 automates the documentation trail for each transmission, tracks CPT code eligibility in real time, and surfaces billing opportunities through an administrative dashboard. Practices implementing Rhythm360 have achieved up to a 300% increase in captured revenue through more complete CPT code documentation, improved staff efficiency, and the addition of RPM service lines for heart failure and hypertension management under codes including 99453, 99454, and 99457. The platform supports billing compliance, while clinical and operational decisions around revenue remain with the practice.
Rhythm360 is built specifically to unify CIED data from all major OEMs with AI-powered triage, automated documentation, and bi-directional EHR integration in a single cloud-based environment. The following table demonstrates how each technical capability translates directly into measurable improvements in transmissibility, response time, revenue capture, and large-scale report management.
| Rhythm360 Capability | Quantified Practice Outcome |
|---|---|
| Redundant data feeds + computer vision ingestion across all OEMs | >99.9% transmissibility |
| AI-powered alert triage with optional 24/7 CCT oversight | Critical alerts handled in a fraction of prior response time, reflecting an 80% improvement over manual workflows |
| Automated CPT documentation and billing dashboard | Substantial revenue lift, with practices reporting up to a 3x increase in captured remote monitoring revenue |
| Single unified dashboard replacing multi-OEM portal logins | Tens of thousands of annual reports managed at UCM with stable dismissal rates |
Real-World Saturday Morning Intervention: A device technician receives a prioritized Rhythm360 alert at 8:00 a.m. on a Saturday. The platform has flagged new-onset atrial fibrillation in a 71-year-old pacemaker patient, a transmission that would have sat unreviewed in a single-OEM portal queue until Monday. The on-call electrophysiologist reviews the transmission on the Rhythm360 mobile app, confirms the arrhythmia, and initiates anticoagulation protocols by Saturday afternoon. Without a unified, continuously monitored platform, that event would likely have gone undetected for days, with stroke risk increasing for every hour of delay.
See the unified monitoring environment in action and evaluate how Rhythm360 could change your team’s weekend and after-hours response.
Vendor-neutral platforms consolidate transmission data from all manufacturers into a single documentation environment, which means every qualifying remote interrogation, regardless of device brand, is captured, timestamped, and linked to the appropriate CPT code. Single-OEM portals only document activity for their own devices, leaving multi-OEM practices with incomplete records and missed billing opportunities. Rhythm360 tracks CPT code eligibility in real time across the entire device population, generates auditable documentation for each transmission, and surfaces billing gaps through an administrative dashboard. Practices using this approach have achieved up to a 300% increase in captured revenue from remote monitoring codes including 93298, 99454, and related RPM codes.
The evidence spans multiple independent studies and patient populations. Studies such as the 2023 Trento analysis, TELESAT PRIOR-HF, and subsequent meta-analyses consistently show reductions in cardiovascular hospitalizations, HF-related admissions, and total hospital days. The mechanism remains consistent across these data sets, with earlier detection of arrhythmias and device abnormalities enabling intervention before clinical deterioration requires emergency or inpatient care.
Standard OEM alert systems generate notifications based on device-programmed thresholds, without cross-referencing patient history, prior transmission patterns, or clinical context. The result is a high volume of non-actionable alerts that contribute to clinician fatigue and can cause genuinely critical events to be deprioritized. AI-powered triage applies pattern recognition across the full data stream to distinguish routine transmissions from clinically significant events, ranks alerts by urgency, and filters noise before it reaches the clinical queue. Rhythm360’s triage layer operates across all connected OEM data simultaneously, so a practice managing Medtronic, Boston Scientific, and Abbott devices receives a single prioritized alert queue rather than several separate, unranked notification streams. The outcome is an 80% reduction in critical alert response times.
Remote monitoring does not eliminate in-office visits entirely, but it replaces the majority of scheduled routine interrogations with clinically indicated follow-up. The TRUST trial found a 45% reduction in total in-hospital device evaluations without affecting morbidity. University Hospitals of Leicester’s cardiac remote monitoring pilot achieved reductions in hospitalization rates. The visits that remain are targeted, with patients called in when the remote data indicates a specific clinical need rather than on a fixed calendar schedule. This model improves resource allocation, reduces unnecessary patient travel, and concentrates in-person clinical capacity on the patients who need it most. Practices using Rhythm360 benefit from automated scheduling prompts triggered by clinical thresholds rather than arbitrary time intervals.
Implementation scope depends on practice size, EHR system, and the number of OEM data feeds being consolidated. Rhythm360 integrates bi-directionally with Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and other systems via HL7, and connects directly to Medtronic, Boston Scientific, Abbott, Biotronik, and other device manufacturers. The onboarding process, including EHR integration setup, typically takes from a few days to a few weeks. The platform is cloud-based and SaaS-priced, scaling with clinic size and usage rather than requiring large upfront infrastructure investment. Staff training focuses on the unified dashboard and mobile application, which reduces reliance on OEM-specific expertise and improves operational resilience when personnel changes occur.
Fragmented OEM portals, manual alert workflows, and incomplete CPT documentation are not inevitable features of cardiac device management. They reflect operating without a unified platform. The clinical evidence is consistent, showing that remote pacemaker monitoring detects arrhythmias days earlier than conventional follow-up, reduces cardiovascular hospitalizations by measurable margins, and enables same-day intervention for events that would otherwise wait for the next scheduled visit. The operational and financial evidence is equally clear, with automated documentation capturing revenue that manual workflows miss and a single consolidated dashboard reducing the staff burden that drives burnout and turnover in device clinics.
Rhythm360 delivers these outcomes across all OEMs simultaneously, with greater than 99.9% transmissibility, 80% faster critical alert response, and up to 300% revenue lift, supported by real-world data from high-volume academic centers and independent clinical studies.
Find out how much revenue your current workflow is leaving behind and explore how Rhythm360 can consolidate your device population while reducing alert fatigue for your team.
